108 related articles for article (PubMed ID: 9238302)
1. Minimizing the problem of poor compliance in adolescents. Clinical experience with a modern low-dose gestodene-containing oral contraceptive.
Brill K
Ann N Y Acad Sci; 1997 Jun; 816():457-65. PubMed ID: 9238302
[TBL] [Abstract][Full Text] [Related]
2. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
Endrikat J; Müller U; Düsterberg B
Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
Weber-Diehl F; Lehnert J; Lachnit U
Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
[TBL] [Abstract][Full Text] [Related]
4. Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents.
Leonard F; Gaspard U; Theunissen L
Curr Med Res Opin; 1993; 13(2):78-86. PubMed ID: 8325045
[TBL] [Abstract][Full Text] [Related]
5. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
6. The acceptance of a 7-week cycle with a modern low-dose oral contraceptive (Minulet).
Kornaat H; Geerdink MH; Klitsie JW
Contraception; 1992 Feb; 45(2):119-27. PubMed ID: 1559335
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents.
Brill K; Schnitker J; Albring M
Adv Contracept; 1994 Dec; 10(4):237-47. PubMed ID: 7740990
[TBL] [Abstract][Full Text] [Related]
8. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
Lammers P; op ten Berg M
Acta Obstet Gynecol Scand; 1991; 70(6):497-500. PubMed ID: 1837199
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
Brill K; Norpoth T; Schnitker J; Albring M
Contraception; 1991 Feb; 43(2):101-10. PubMed ID: 2040166
[TBL] [Abstract][Full Text] [Related]
10. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
11. A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gestodene Study Group.
Bruni V; Croxatto H; De La Cruz J; Dhont M; Durlot F; Fernandes MT; Andrade RP; Weisberg E; Rhoa M
Gynecol Endocrinol; 2000 Apr; 14(2):90-8. PubMed ID: 10836195
[TBL] [Abstract][Full Text] [Related]
12. Menstrual impact of contraception.
Stubblefield PG
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
[TBL] [Abstract][Full Text] [Related]
13. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
Corson SL
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
[TBL] [Abstract][Full Text] [Related]
15. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
16. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinylestradiol.
de Voogd WS
Contraception; 1991 Aug; 44(2):107-12. PubMed ID: 1832627
[TBL] [Abstract][Full Text] [Related]
17. Metabolic changes during treatment with two different progestogens.
Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of a low-dose contraceptive--Femodene].
Rachev E; Damianov L; Dukovski A; Katsarova M
Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women.
Kuhnz W
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2120-7. PubMed ID: 2124087
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
